PLACEBO-CONTROLLED STUDY OF MESULERGINE IN PARKINSONS-DISEASE

被引：11

作者：

JANKOVIC, J ^{[1
]}

ORMAN, J ^{[1
]}

JANSSON, B ^{[1
]}

机构：

[1] TEXAS MED CTR,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030

来源：

NEUROLOGY | 1985年 / 35卷 / 02期

关键词：

D O I：

10.1212/WNL.35.2.161

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：161 / 165

页数：5

共 30 条

[1]

[Anonymous], 1982, MOVEMENT DISORD

[2] THERAPEUTIC EXPERIENCE WITH THE NEW DOPAMINE AGONIST CU-32-085 IN ADVANCED PARKINSONS-DISEASE [J].

BIESEMEYER, H ;

LUDIN, HP ;

RINGWALD, E .

JOURNAL OF NEUROLOGY, 1983, 230 (01) :19-23

[3] A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONS-DISEASE [J].

CANTER, GJ ;

DELATORRE, R ;

MIER, M .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1961, 133 (02) :143-147

[4]

CREESE I, 1982, J CLIN PSYCHOPHARM, V2, P239

[5] BIPHASIC INFLUENCE OF A 8-ALPHA-AMINO ERGOLINE, CU 32-085, ON STRIATAL DOPAMINE SYNTHESIS AND TURNOVER INVIVO IN THE RAT [J].

ENZ, A .

LIFE SCIENCES, 1981, 29 (21) :2227-2234

[6]

FLUCKIGER E, 1979, EXPERIENTIA, V35, P1677, DOI 10.1007/BF01953267

[7] BEHAVIORAL CORRELATIONS OF DOPAMINE RECEPTOR ACTIVATION [J].

GERSHANIK, O ;

HEIKKILA, RE ;

DUVOISIN, RC .

NEUROLOGY, 1983, 33 (11) :1489-1492

[8] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[9]

HOEHN MM, 1983, ANN NEUROL, V14, P111

[10]

ILSON J, 1983, LISURIDE OTHER DOPAM, P443

← 1 2 3 →